No definition available.
Filter registries Oper. in, Oper. out
Check pre-conditions None
Include endpoints None
Check conditions None
Apply sex-specific rule None
DM_EYE_OPER_VEGF_INJECT_VITR
Extra metadata
List of similar endpoints to
Injection of anti-VEGF-antibody or corticosteroid or any drug into vitreous body
based on the number of shared cases.
Broader endpoints:
Narrower endpoints:
None
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 3255 | 1584 | 1671 |
| Unadjusted prevalence (%) | 1.25 | 1.08 | 1.48 |
| Mean age at first event (years) | 68.40 | 69.72 | 67.16 |
| Follow-up | Absolute risk | HR [95% CI] | p | N |
|---|---|---|---|---|
| 1998–2019 | 0.08 | 5.24 [4.02, 6.83] | 1.7e-34 | 352 |
| 15 years | 0.04 | 5.24 [4.02, 6.83] | 1.7e-34 | 352 |
| 5 years | - | - | - | - |
| 1 year | - | - | - | - |
Index endpoint: DM_EYE_OPER_VEGF_INJECT_VITR – Injection of anti-VEGF-antibody or corticosteroid or any drug into vitreous body
GWS hits:
before Injection of anti-VEGF-antibody or corticosteroid or any drug into vitreous body
after Injection of anti-VEGF-antibody or corticosteroid or any drug into vitreous body
Loading survival analyses plot
Loading survival analyses table